Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials

Primo N Lara, Mary W. Redman, Karen Kelly, Martin J. Edelman, Stephen K. Williamson, John J. Crowley, David R Gandara

Research output: Contribution to journalArticle

148 Scopus citations

Fingerprint Dive into the research topics of 'Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: Results from Southwest Oncology Group randomized trials'. Together they form a unique fingerprint.

Medicine & Life Sciences